COMMUNIQUÉS West-GlobeNewswire

BioPorto Announces Annual Report 2018

22/02/2019 - 08:31

February 22, 2019 Announcement no. 2 Annual Report 2018 Full speed ahead Highlights from the Annual Report 2018 Revenue growth of 80% from sales of The NGAL Test™ in U.S. and 18% in rest of the world in 2018 Total [...]

Novo Nordisk: Notice for the Annual General Meeting of Novo Nordisk A/S

22/02/2019 - 08:03

Bagsværd, Denmark, 22 February 2019 - The Annual General Meeting of Novo Nordisk A/S will be held on: - Thursday 21 March 2019 at 2.00 pm (CET) at Bella Center, Center Boulevard 5, DK-2300 Copenhagen S, Denmark. The [...]

Xbrane Biopharma releases Year-end report for 2018

22/02/2019 - 08:01

Press release 2019-02-22 Xbrane Biopharma AB's (publ.) (" Xbrane ") Year-end report for 2018 is now available on the Company's website, www.xbrane.com . The fourth quarter 2018 in summary Revenue amounted to SEK 4,896 [...]

Notice of Nexstim Plc 2018 Full Year Results

22/02/2019 - 08:01

Company announcement, Helsinki, 22.02.2019 at 9am (EET) Notice of Nexstim Plc 2018 Full Year Results Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), the targeted neuromodulation company developing and [...]

Spineway :

22/02/2019 - 08:00

The shareholders of Spineway are invited to attend the Ordinary and Extraordinary General Shareholders’ Meeting to be held on Friday, 8 March 2019, at noon , at the company’s registered office. Notice of the meeting [...]

SPINEWAY : Modalités de mise à disposition des documents prépartoires à l’Assemblée Générale du 8 mars 2019

22/02/2019 - 08:00

Les actionnaires de Spineway sont invités à participer à l’Assemblée Générale Mixte qui se déroulera au siège social de la société le vendredi 8 mars 2019 à 12 heures. L’avis de réunion comportant l’ordre du jour et les [...]

NeuroSearch – Updated financial calendar for 2019

22/02/2019 - 08:00

Announcement 22 February 2019 NeuroSearch A/S (NEUR) hereby announces an updated company’s financial calendar for 2019. 25 February 2019 Annual Report 2018 29 April 2019 Annual General Meeting 30 August 2019 Interim [...]

ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.

22/02/2019 - 07:17

Amsterdam, the Netherlands – 22 February 2019 Esperite N.V. (Euronext: ESP) and Polski Bank Komórek Macierzystych S.A. (WSE: PBKM) are pleased to announce that they have entered into an Memorandum of Understanding (MoU [...]

ObsEva SA to Participate in Upcoming Investor Conferences

22/02/2019 - 07:00

Geneva, Switzerland and Boston, MA – February 22, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]

Clarification Regarding Press Release Issued by Unrelated Third Party

22/02/2019 - 05:07

TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”), is providing an update regarding a press release (the “ Press Release ”) issued [...]

Early Warning News Release

22/02/2019 - 02:02

VANCOUVER, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Drew Malcolm (“ Malcolm ”), a shareholder of Ascent Industries Corp. (the “ Issuer ”) makes the following announcement in accordance with National [...]

Cronos Group Inc. Shareholders Approve C$2.4 Billion Strategic Investment from Altria Group, Inc.

21/02/2019 - 23:34

TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced that at a Special Meeting held today, the Company’s shareholders overwhelmingly [...]

Alder BioPharmaceuticals® to Present at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 23:17

BOTHELL, Wash., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

bioLytical Laboratories Earns MDSAP Certification, Highest Quality Standard in Medical Device Industry

21/02/2019 - 23:00

Audits confirm bioLytical’s Quality Management System fulfils latest standards for multiple regulatory jurisdictions including US FDA and Health Canada. RICHMOND, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]

Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2018

21/02/2019 - 22:59

HOUSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical-stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Profound Medical to Release Fourth Quarter and Full Year 2018 Financial Results on March 7 – Conference Call to Follow

21/02/2019 - 22:30

TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR [...]

Flexion Therapeutics Announces New In Vitro Data Showing Protective Effects of Triamcinolone Acetonide on Cartilage

21/02/2019 - 22:30

Study conducted in collaboration with MIT showed that triamcinolone acetonide had protective effects on inflamed and/or injured cartilage in an established preclinical model Data presented in “late breaker” session at [...]

Globus Medical Reports Full Year and Fourth Quarter 2018 Results

21/02/2019 - 22:15

AUDUBON, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, [...]

KemPharm to Report Fourth Quarter and Year End 2018 Results

21/02/2019 - 22:15

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, February 28, 2019, 4:30 p.m. ET CELEBRATION, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq:KMPH), a specialty [...]